Data as of Jan 29
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 6.96, with a high estimate of 6.96 and a low estimate of 6.96. The median estimate represents a +79.48% increase from the last price of 3.88.
The current consensus among 1 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.